10 employees
Interface Biologics develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices.
2001
$5M
from 2 investors over 2 rounds
Interface Biologics raised undisclosed on January 13, 2015
Investors: DSM Venturing
Interface Biologics raised $5M on December 9, 2008
Investors: BDC Capital